Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies

Dan Grandér, Pedram Kharaziha, Edward Laane, Katja Pokrovskaja, Theocharis Panaretakis

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

Glucocorticoids are fundamental drugs used in the treatment of lymphoid malignancies with apoptotic cell death as the hitherto proposed mechanism of action. We have recently shown that dexamethasone induces autophagy in lymphoid leukemia cells and in this particular setting this cell death modality is a prerequisite for the efficient killing of the leukemic cells by dexamethasone. 1 Hence, inhibition of autophagy by siRNA-mediated silencing of Beclin 1, as well as chemical inhibition of type III PtdIns3K, inhibits apoptosis, demonstrating an important role of autophagy in dexamethasone-induced cell death. In this brief report, we review these findings and introduce the multiple myeloma cells as a novel system to study autophagy in response to dexamethasone.

Original languageEnglish (US)
Pages (from-to)1198-1200
Number of pages3
JournalAutophagy
Volume5
Issue number8
DOIs
StatePublished - Nov 16 2009
Externally publishedYes

Keywords

  • AKT
  • Autophagy
  • Cell death
  • Glucocorticoids
  • Hematological malignancies
  • PML

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies'. Together they form a unique fingerprint.

Cite this